Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia

NCT00399971 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia, Aplastic

Interventions

PROCEDURE: Ex Vivo Immunotherapy
DRUG: Ex vivo immunotherapy

Sponsor

Shenzhen Zhongxing Yangfan Biotech Co. Ltd.

Collaborators

[object Object]
[object Object]